Publications by authors named "Ximing Tang"

59Publications

Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration.

iScience 2018 Nov 2;9:451-460. Epub 2018 Nov 2.

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.isci.2018.10.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249353PMC
November 2018

The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 Oct;34(30):3638-3647

Vassiliki Papadimitrakopoulou, J. Jack Lee, Ignacio I. Wistuba, Anne S. Tsao, Frank V. Fossella, Neda Kalhor, Sanjay Gupta, Lauren Averett Byers, Julie G. Izzo, Ximing Tang, Ferdinandos Skoulidis, Don L. Gibbons, Li Shen, Caimiao Wei, Lixia Diao, S. Andrew Peng, Jing Wang, Alda L. Tam, John V. Heymach, and Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, TX; Scott N. Gettinger, Sarah B. Goldberg, Ja Seok Koo, and Roy S. Herbst, Yale University, New Haven, CT; Vincent A. Miller, Foundation Medicine, Cambridge, MA; Kevin R. Coombes, Ohio State University College of Medicine, Columbus, OH; and David J. Mauro and Eric H. Rubin, Merck, North Wales, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.0084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065110PMC
October 2016

Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.

Cell Rep 2016 08 28;16(6):1614-1628. Epub 2016 Jul 28.

Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981512PMC
August 2016

Corrigendum to "PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer" [ 18 (2016) 282-293].

Neoplasia 2016 Jul 17;18(7):457. Epub 2016 Jul 17.

Department of Internal Medicine and Simmons, Comprehensive Cancer Center, University of Texas, Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.06.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954933PMC
July 2016

PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer.

Neoplasia 2016 May 16;18(5):282-293. Epub 2016 Apr 16.

Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887597PMC
May 2016

Pleuropulmonary Meningothelial Proliferations: Evidence for a Common Histogenesis.

Am J Surg Pathol 2015 Dec;39(12):1673-8

Departments of *Pathology †Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX ‡Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/9000/00000/Pleuropulmonary
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000489DOI Listing
December 2015

An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.

Hum Pathol 2015 Jun 20;46(6):836-42. Epub 2015 Feb 20.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177150005
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2014.10.032DOI Listing
June 2015

ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis.

Cell Rep 2015 Mar 5;10(9):1599-1613. Epub 2015 Mar 5.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.02.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405934PMC
March 2015

Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.

Hum Pathol 2014 Dec 6;45(12):2463-70. Epub 2014 Sep 6.

Department of Pathology, MD Anderson Cancer Center, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.08.013DOI Listing
December 2014

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.

Lung Cancer 2014 Jul 22;85(1):88-93. Epub 2014 Apr 22.

Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090351PMC
July 2014

Identification of a subset of human non-small cell lung cancer patients with high PI3Kβ and low PTEN expression, more prevalent in squamous cell carcinoma.

Clin Cancer Res 2014 Feb 27;20(3):595-603. Epub 2013 Nov 27.

Authors' Affiliations: AstraZeneca R&D; Former AstraZeneca, Macclesfield, Cheshire, United Kingdom; Departments of Translational Molecular Pathology and Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; AstraZeneca, Asia and Emerging Markets iMed, Shanghai, China; Novartis Institutes for BioMedical Research, Basel, Switzerland; and Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1638DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503252PMC
February 2014

Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial.

Clin Cancer Res 2013 Dec 28;19(24):6967-75. Epub 2013 Oct 28.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Biostatistics and Applied Mathematics, Translational Molecular Pathology, Diagnostic Imaging, Diagnostic Radiology, and Bioinformatics and Computational Biology; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; The Hamon Center for Therapeutic Oncology Research and Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Charlotte, North Carolina; Medical Oncology, Yale Cancer Center, New Haven, Connecticut; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario; Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland; UC San Diego Moores Cancer Center, La Jolla, California; and Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905243PMC
December 2013

EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.

Clin Cancer Res 2013 Dec 4;19(23):6556-65. Epub 2013 Oct 4.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Pathology, Biostatistics, Thoracic Surgery, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and The University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890101PMC
December 2013

Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.

Mod Pathol 2013 Dec 21;26(12):1554-60. Epub 2013 Jun 21.

Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.111DOI Listing
December 2013

Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.

J Thorac Oncol 2013 Apr;8(4):436-42

Department of Diagnostic Radiology, Unit 1471, The University of Texas, M.D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318287c91eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879952PMC
April 2013

HER family receptor and ligand status in thymic carcinoma.

Lung Cancer 2012 Sep 20;77(3):515-21. Epub 2012 Jun 20.

Department of Pathology, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S0169500212003777/1-s2.0-S016950021200
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S016950021200377
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2012.05.108DOI Listing
September 2012

Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.

Sci Transl Med 2012 May;4(136):136ra70

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3003513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836384PMC
May 2012

A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck.

Clin Cancer Res 2012 Mar 18;18(5):1435-46. Epub 2012 Jan 18.

Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167936PMC
March 2012

Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.

Clin Cancer Res 2011 Apr 21;17(8):2434-43. Epub 2011 Jan 21.

Departmentsof Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078948PMC
April 2011

Biological activity of celecoxib in the bronchial epithelium of current and former smokers.

Cancer Prev Res (Phila) 2010 Feb 26;3(2):148-59. Epub 2010 Jan 26.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0233DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028718PMC
February 2010

HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.

Clin Cancer Res 2009 Aug 21;15(15):4829-37. Epub 2009 Jul 21.

Departments of Pathology, Thoracic/Head and Neck Medical Oncology, Biostatistics, and Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372920PMC
August 2009

Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma.

J Cutan Pathol 2010 Feb 15;37(2):231-6. Epub 2009 Jul 15.

Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0560.2009.01316.xDOI Listing
February 2010

Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.

Cancer Prev Res (Phila) 2008 Aug;1(3):192-200

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369271PMC
August 2008

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Clin Cancer Res 2007 May;13(10):2890-6

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-3043DOI Listing
May 2007

Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.

Cancer 2006 Dec;107(11):2637-46

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22315
Publisher Site
http://dx.doi.org/10.1002/cncr.22315DOI Listing
December 2006

EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.

Cancer Res 2005 Sep;65(17):7568-72

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/65/17/7568.full.pd
Web Search
http://dx.doi.org/10.1158/0008-5472.CAN-05-1705DOI Listing
September 2005

Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.

Mol Cancer Res 2004 Dec;2(12):685-91

Molecular Biology Laboratory, Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Unit 432, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
December 2004

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

J Clin Oncol 2004 Nov;22(22):4575-83

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.01.091DOI Listing
November 2004

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.

J Clin Oncol 2004 Aug;22(16):3230-7

Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2004.02.080
Publisher Site
http://dx.doi.org/10.1200/JCO.2004.02.080DOI Listing
August 2004

Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.

Clin Cancer Res 2003 May;9(5):1785-91

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
May 2003

Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.

Cancer Res 2002 Sep;62(17):4903-8

Department of Gastrointestinal Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
September 2002

Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.

Clin Exp Metastasis 2002 ;19(4):319-26

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1015515119300DOI Listing
July 2002